Utility of biochemical models predictive of liver fibrosis grade in inmates with hepatitis C;Utilidad de 2 modelos bioquímicos predictivos del grado de fibrosis hepática en la población penitenciaria con hepatitis C

Gastroenterologia y Hepatologia

Volumn 32, Issue 6, 2009, Pages 387-394

  Portilla, Joaquín ^a   López Burgos, Antonio ^b   Saiz De La Hoya Zamácola, Pablo ^c   Sánchez Payá, José ^a   Bedía Collantes M, Miguel ^c   Faraco Atienzar, Inmaculada ^b   Lissen, Eduardo ^d  

^a HOSPITAL GENERAL UNIVERSITARIO DE ALICANTE   (Spain)

^b Centro Penitenciario de Sevilla   (Spain)

^c Centro Penitenciario Fontcalent   (Spain)

^d HOSPITAL UNIVERSITARIO VIRGEN DEL ROCÍO   (Spain)

Author keywords

Biochemical tests; Hepatitis C; Liver fibrosis; Prisons

Indexed keywords

ADULT; APRI; ARTICLE; CONTROLLED STUDY; CROSS-SECTIONAL STUDY; DIAGNOSTIC VALUE; DISEASE CLASSIFICATION; DISEASE SEVERITY; FEMALE; FIB 4; HEPATITIS C; HUMAN; LABORATORY TEST; LIVER BIOPSY; LIVER FIBROSIS; MAJOR CLINICAL STUDY; MALE; PRISONER; PROGNOSIS; SENSITIVITY AND SPECIFICITY;

ADULT; ALANINE TRANSAMINASE; AREA UNDER CURVE; ASPARTATE AMINOTRANSFERASES; BIOPSY; CROSS-SECTIONAL STUDIES; FEMALE; GENOTYPE; HEPACIVIRUS; HEPATITIS C, CHRONIC; HIV INFECTIONS; HUMANS; LIVER CIRRHOSIS; MALE; MIDDLE AGED; MODELS, BIOLOGICAL; PREDICTIVE VALUE OF TESTS; PRISONERS; PROSPECTIVE STUDIES; SENSITIVITY AND SPECIFICITY; SEVERITY OF ILLNESS INDEX; SPAIN; SUBSTANCE ABUSE, INTRAVENOUS;

EID: 67649408738     PISSN: 02105705     EISSN: 15789519     Source Type: Journal    
DOI: 10.1016/j.gastrohep.2009.01.176     Document Type: Article

References (27)

1. Morillas M. Consenso para el tratamiento de las hepatitis B y C. Monitorización y biopsia. Gastroenterol Hepatol 29 (2006) 121-124
2. Yee H.S., Currie S.L., Darling J.M., and Wright T.L. Management and treatment of hepatitis C viral infection: Recommendations from the Department of Veterans Affairs Hepatitis C Resource Center Program and the National Hepatitis C Program Office. Am J Gastroenterol 101 (2006) 2360-2378
3. Strader D.B., Wright T., Thomas D.L., and Seeff L.B. American Association for the Study of Liver Diseases. Diagnosis, management and treatment of hepatitis C. Hepatology 39 (2004) 1147-1171
4. Palacios Pérez A., and Salmerón Escobar J. Role of liver biopsy in the diagnosis and management of chronic hepatitis C. Gastroenterol Hepatol 30 (2007) 402-407
5. Ubiña Aznar E., Mendez Sánchez I., Rivera Irigoin R., Vera Rivero F., Fernández Moreno N., García Fernández G., et al. Liver biopsy in patients with chronic hepatitis C virus infection: Experience in a district hospital. Gastroenterol Hepatol 29 (2006) 443-446
6. Saadeh S., Cammell G., Carey W.D., Younossi Z., Barnes D., and Easley K. The role of liver biopsy in chronic hepatitis C. Hepatology 33 (2001) 196-200
7. Dienstag J. The role of liver biopsy in chronic hepatitis C. Hepatology 36 (2002) 152-160
8. Saiz De la Hoya P., Bedia M., Murcia J., Cebriá J., Sánchez-Payá J., and Portilla J. Factores predictivos de infección por el VIH, VHC y coinfección en la población reclusa de una prisión española. Enferm Infecc Microbiol Clin 23 (2005) 53-57
9. Saiz De la Hoya-Zamácola P., Marco-Mouriño A., Clemente-Ricote G., Portilla-Sogorb J., Boix Martínez V., Nuñez Martínez O., et al. Recomendaciones de expertos sobre el diagnóstico y tratamiento de la hepatitis C crónica en el medio penitenciario. Gastroenterol Hepatol 29 (2006) 551-559
10. Forns X., Ampurdanes S., Llovet J.M., Aponte J., Quinto L., Martínez-Bauer E., et al. Identification of chronic hepatitis C patients without hepatic fibrosis by a simple predictive model. Hepatology 36 (2002) 986-992
11. Halfton P., Bourliere M., Deydier R., Botta-Fridlund D., Renou C., Tran A., et al. Independent prospective multicenter validation of biochemical markers (Fibrotest-Actitest) for the prediction of liver fibrosis and activity in patients with chronic hepatitis C: The Fibropaca Study. Am J Gastroenterol 101 (2006) 547-555
12. Myers R.P., Benhamou Y., Imbert-Bismut F., Thibault V., Bochet M., Charlotte F., et al. Serum biochemical markers accurately predict liver fibrosis in HIV and hepatitis C virus co-infected patients. AIDS 17 (2003) 721-725
13. Wai C.T., Greenson J.K., Fontana R.J., Kalbfleisch J.D., Marrero J.A., and Conjeevaram H.S. A simple non invasive index can predict both significant fibrosis and cirrhosis in patients with chronic hepatitis C. Hepatology 38 (2003) 518-526
14. Sterling R.K., Lissen E., Clumeck M., Sola R., Correa M.C., Montaner J., et al. Developement of a simple non invasive index to predict significant fibrosis in patient with HIV/HCV coinfection. Hepatology 42 (2006) 282-292
15. Vallet-Pichard A., Mallet V., and Pol S. FIB-4: A simple, inexpensive and accurate marker of fibrosis in HCV-infected patients. Hepatology 44 (2006) 769
16. Rossi E., Adams L., Prins A., Bulsara M., De Boer B., Garas G., et al. Validation of the FibroTest Biochemical Markers Scores in assessing liver fibrosis in Hepatitis C patients. Clinical Chemistry 3 (2003) 450-454
17. Adams L.A., Bulsara M., Rossi E., De Boer B., Speers D., George J., et al. Hepascore: An accurate validated predictor of liver fibrosis in chronic hepatitis C infection. Clinical Chemistry 51 (2005) 1867-1873
18. García-Guerrero J., Saiz De la Hoya P., Portilla J., Marco A., Sánchez-Paya J., Moreno S., et al. Prevalence of HIV-1 drug resistance mutations among Spanish prison inmates. Eur J Clin Microbiol Infect Dis 25 (2006) 695-701
19. Poynard T., Munteanu M., Imbert-Bismut F., Charlotte F., Thabut D., Le Calvez S., et al. Prospective analysis of discordant results between biochemical markers and biopsy in patients with chronic hepatitis C. Clin Chem 10 (2004) 10
20. Imbert-Bismuth F., Ratziu V., Pieroni L., Charlottte F., Benhamou Y., and Poynard T. Biochemical markers of liver fibrosis in patients with hepatitis C virus infection: A prospective study. Lancet 357 (2001) 1069-1075
21. Iacobellis A., Mangia A., Leandro G., Clemente R., Festa V., Attino V., et al. External validation of biochemical indices for non invasive evaluation of liver fibrosis in HCV chronic hepatitis. Am J Gastroenterol 100 (2005) 868-873
22. Poynard T., Imbert-Bismut F., Munteanu M., Messous D., Myers R.P., Thabut D., et al. Overview of the diagnostic value of biochemical markers of liver fibrosis (Fibrotest, HCV Fibrosure) and necrosis (ActiTest) in patients with chronic hepatitis C. Comparative Hepatology 3 (2004) 8
23. Leroy V., Hilleret M.N., Sturm N., Trocme C., Renversez J.C., Faure P., et al. Prospective comparison of six non-invasive scores for the diagnosis of liver fibrosis in chronic hepatitis C. J Hepatol 46 (2007) 775-782
24. Soriano V., Puoti M., Sulkowski M., Mauss S., Cacoub P., Carqnel A., et al. Care of patients with hepatitis C and HIV co-infection. AIDS 18 (2004) 1-12
25. ®), un nuevo método no invasivo en la valoración de la fibrosis hepática. Med Clin 126 (2006) 220-221
26. Ziol M., Handra-Luca A., Kettaneh A., Christidis C., Mal F., Kazemi F., et al. Non invasive assessment of liver fibrosis by measurement of stiffness in patients with chronic hepatitis C. Hepatology 41 (2005) 48-54
27. Castera L., Vergniol J., Foucher J., Le Bail B., Chanteloup E., Haser M., et al. Prospective comparison of transient elastography, Fibrotest, APRI and liver biopsy for the assessment of fibrosis in chronic hepatitis C. Gastroenterology 128 (2005) 343-350